[Effectiveness of treatment and prophylactic methods in persons with ischemic heart disease risk factors]

Insights

Prophylactic measures effectively reduced coronary arterial disease (CAD) and stroke risk in adults with risk factors. This seven-year study confirmed significant reductions in mortality for men and women with CAD risk factors undergoing treatment.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Coronary arterial disease (CAD) poses a significant health burden.
  • Identifying individuals with risk factors for CAD is crucial for preventive strategies.
  • Early intervention can mitigate the progression of cardiovascular diseases.

Purpose of the Study:

  • To evaluate the efficacy of prophylactic interventions in individuals with coronary arterial disease risk factors (RF CAD).
  • To assess the impact of these measures on the incidence of CAD, stroke, and overall mortality.

Main Methods:

  • A prospective study involving an unorganized population aged 30-59.
  • Diagnosis of CAD using standard epidemiologic methods.
  • Assessment of hemostasis system function and total blood cholesterol using two screening systems.
  • Seven-year follow-up period.

Main Results:

  • The implemented prophylactic methods demonstrated significant effectiveness in both men and women with RF CAD.
  • A considerable reduction in the likelihood of developing CAD and stroke was observed.
  • Mortality rates were substantially decreased in the treated group.

Conclusions:

  • Comprehensive prophylactic treatment is highly effective in managing individuals with coronary arterial disease risk factors.
  • These interventions play a vital role in preventing cardiovascular events and reducing mortality.
  • Public health strategies should prioritize the implementation of such prophylactic measures.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...